National governments and international agencies, including programmes like the Global Alliance for Vaccines and Immunizations and the Global Fund to Fight AIDS, Tuberculosis and Malaria, have committed to scaling up health interventions and to meeting the Millennium Development Goals (MDGs), and need information on costs of scaling up these interventions. However, there has been no systematic attempt across health interventions to determine the impact of scaling up on the costs of programmes.
Introduction
In 2000, the United Nations proclaimed the Millennium Development Goals, many targeting health (United Nations 2002). The 2001 Report of the Commission on Macroeconomics and Health (CMH) added impetus to meet these goals (Commission on Macroeconomics and Health 2001), while the aim of the Global Alliance for Vaccines and Immunizations and the Global Fund to Fight AIDS, Tuberculosis and Malaria is to increase the coverage of health interventions. The staff behind these policies and programmes, together with local and national policy makers, need information on financial outlays to plan for and to reach their targets; specifically, they need to analyze changes in costs when health interventions are 'scaled up' to reach greater percentages of the population. For example, they may be interested in the cost of extending health interventions to the poorest people in their country, who often live in rural or remote areas previously not serviced (World Bank 1993; Midhet et al. 1998; Ali et al. 2001; Berhane et al. 2001; Hjortsberg and Mwikisa 2002; Thind and Andersen 2003) . Without a means of determining the costs of expanding health interventions, policy makers cannot assess the feasibility or sustainability of scaling up interventions. Despite this need, there has not yet been a systematic attempt to determine how scaling up affects the costs of health programmes.
There are many definitions and purposes of scaling up (Uvin 1995) . This paper focuses on the cost of increasing the scope or scale of services to serve more individuals. This includes expanding the geographic supply of an intervention and increasing the demand among the population for an intervention.
The cost of producing outputs is a function of the cost of the mix of inputs and technologies used in production. Economic theories posit that changes in the levels of output may mean average costs change in both the long and short run. In order to increase output, the inputs used in production also need to be increased. Microeconomic theory defines short-run increases in production as increases that are possible by changing one of the inputs to production (the variable inputs, e.g. drugs), while the other inputs are assumed constant (the fixed inputs, which are usually thought of as capital). Increasing the variable input will, eventually, result in inefficient use of the fixed inputs. For example, hiring more workers to operate one machine may at first increase production at the same or even reduced costs per output since the workers can operate the machine when it previously was not used (e.g. at night), but as more workers are hired the cost per unit output will increase when the machine is fully used and workers are forced to utilize other technologies to produce output (e.g. making outputs by hand) (Perloff 2001) . The cost of producing one more unit of output is the marginal cost; if the cost of producing one more unit of output is higher than the cost of producing the previous unit, this indicates increasing marginal costs.
In the long run, on the other hand, microeconomic theory assumes that all resources used in production can be varied; for example, new buildings can be built, new people trained, etc. This does not necessarily mean that the cost structure remains static. For example, doubling all inputs could exactly double output (constant returns to scale), more than double output (economies of scale) or produce less than double the amount of output (diseconomies of scale) (Perloff 2001 ). However, it may be that certain inputs, such as skilled labour, are in low supply, or, in the case of governments trying to scale up health services, existing policies or externally imposed conditions may freeze public sector hiring (Kiragu 2002) . In the production process, the inability to increase one or more inputs results in a situation similar to the short run. Further, technology shifts may be warranted in both the short run (e.g. overuse of a capital item may result in using other methods) or the long run (e.g. expanding services to remote areas may entail mobile facilities rather than fixed facilities).
Economies of scope are changes to the average cost of production that result from producing two or more outputs at the same time (Perloff 2001) . For example, adding a new antigen to an existing programme for immunizations may cost less than operating an additional, independent programme. However, in countries with little current capacity, adding more health interventions may produce diseconomies of scope, i.e. trying to add new interventions may overload capacity such that current interventions are delivered less efficiently.
A few studies demonstrate changing cost functions at different levels of coverage. The best method for determining changing cost functions would be to collect and analyze cost data in a time-series analysis. If only cross-sectional data are available, econometric analysis can also be used to show the variables that affect costs at different coverage levels. For example, Kumaranayake and Watts (2000a) show increasing average costs in the short-run for HIV/AIDS curative and preventive interventions moving from current coverage to 25% coverage in sub-Saharan Africa. However, many studies tend to take average costs per recipient and multiply them by projected future need to determine the total costs of scaling up, adding caveats on the need to adjust average costs per recipient while noting a lack of evidence for obtaining precise adjustments.
The objectives of this review are twofold. First, it seeks to identify what factors modify cost curves as coverage increases, both in the short and long run. Identification of important factors provides a guide to accounting or adjusting for dis/economies of scale and changing marginal costs when costing health interventions. Secondly, it seeks to describe cost curves for different kinds of interventions and levels of coverage.
Materials and methods
The published English language literature for the period January 1975 -December 2002, inclusive, was searched using several medical subheading (MeSH) terms and text strings to identify articles in Medline and Econlit (see Table 1 ). We also searched the World Health Organization's regional Index Medicus databases and checked the reference lists of published papers. Internet searches were performed for grey literature produced since 1990. Our search revealed 2606 publications of potential relevance in Medline and 954 in Econlit. Internet searches provided an additional 8 articles.
The titles and abstracts of these articles were read to determine relevance to the topic. Articles were included as potentially relevant if they discussed scaling up or implementation in terms that matched the definition provided above. Articles were excluded if they contained no explicit discussion of costs, or did not discuss scaling up or implementation. Citations of articles selected were tracked in ISI Web of Science. Abstract reading and citation tracking resulted in 37 publications that directly addressed the cost of scaling up health interventions. Of these, three discussed the costs of programmes at different levels of coverage by assessing actual programmes after the process of scaling up had occurred (Brenzel and Claquin 1994; Soucat et al. 1997; Fiedler 2001) . These studies present the best evidence available for calculating costs at different levels of coverage and are used as examples throughout the results and discussion section of this paper. Nineteen additional studies, counting the CMH set as one publication, constituted quantitative cost projections (Over 1986; Patel 1986; Cumper 1987; Hart et al. 1991; Mills et al. 1993; Fiedler 1997; Holtgrave et al. 1998; Wilkinson et al. 1998 Wilkinson et al. , 2000 Fiedler et al. 2000; Kumaranayake and Watts 2000b; Kumaranayake et al. 2001; Levin et al. 2001; Saitowitz et al. 2001; Schwartlander et al. 2001; UNECA 2001; World Bank and ACTafrica 2001; Floyd et al. 2002; Khan et al. 2002) . However, four of these articles (Kumaranayake and Watts 2000b; Schwartlander et al. 2001; UNECA 2001; World Bank and ACTafrica 2001) presented essentially the same data with some differences in methods, while two studies used the same methodology for different areas of South Africa (Wilkinson et al. 1998 (Wilkinson et al. , 2000 , reducing the number to 15. Three articles analyze the existence of changing average costs using current cost data (Kass 1987; Edmunds et al. 2000; Kumaranayake and Watts 2000a) , with one (Kumaranayake and Watts 2000a) also including an econometric analysis of changing cost structures. Another 12 articles provided qualitative descriptions of factors affecting costs when interventions are scaled up (Kass 1987; Phillips 1993; Sprinkle et al. 1994; Broomberg et al. 1996; DeRoeck and Levin 1998; Gonzales et al. 1998; Karlsson and Johannesson 1998; Watts and Kumaranayake 1999; Binswanger 2000; Attaran and Sachs 2001; Marseille et al. 2002; Valdmanis et al. 2003) . Of these, three studies represent summaries of data presented in other studies (Broomberg et al. 1996; Watts and Kumaranayake 1999; Binswanger 2000) . All of the studies mentioned are used to identify factors that may affect marginal costs as programmes are scaled up. Once these factors were identified, additional searches were performed to inform the discussion on these topics. Thus, additional studies are included in the results and discussion section. Table 2 lists the number of studies found by geographic region and by intervention for the 22 articles with quantitative data. Forty-five percent of the studies are for countries or areas of sub-Saharan Africa, while none are for Eastern Europe or Latin America.
Analysis
1 Five specific diseases or programmes are addressed by these studies.
None of the studies surveyed use time-series data, and only one includes a follow-up study at a later date (Fiedler 1997 (Fiedler , 2001 . The other studies use data on unit costs from one point in time Mills et al. 1993; Brenzel and Claquin 1994; Floyd et al. 1997; Soucat et al.1997; Khan et al. 2000; Kumaranayake and Watts 2000b; Kumaranayake et al. 2001; Schwartlander et al. 2001; UNECA 2001; World Bank and ACTafrica 2001) or modelled unit costs (Over 1986; Patel 1986; Cumper 1987; Holtgrave et al. 1998 ; Wilkinson et al. Holtgrave et al. (1998) 1998, 2000; Fiedler et al. 2000; Saitowitz et al. 2001) . Most cost projections use micro-costing methods to determine unit costs, which are then multiplied by predicted future need to estimate total costs (Over 1986; Patel 1986; Cumper 1987; Hart 1991; Mills et al. 1993; Fiedler 1997; Floyd et al. 1997; Holtgrave et al. 1998; Wilkinson et al. 1998 Wilkinson et al. , 2000 Fiedler et al. 2000; Khan et al. 2000; Kumaranayake and Watts 2000a; Kumaranayake et al. 2001; Saitowitz et al. 2001; Schwartlander et al. 2001; UNECA 2001; World Bank and ACTafrica 2001) . Two of these used cost projections extrapolated from budgetary expenditures (Fiedler 1997; Floyd et al. 1997) .
Three used econometric models to predict costs (Kass 1987; Kumaranayake and Watts 2000a; Kumaranayake et al. 2001 ).
Eleven of the 15 separate cost projection studies made adjustments to average cost, while four left the unit cost figures unmodified (Patel 1986; Cumper 1987; Holtgrave et al. 1998; Floyd et al. 2002) . Table 3 summarizes how studies adjusted average costs. One study used a quantitative model including a predicted cost curve to adjust costs (Over 1986 ), 10 adjusted costs for regional or country differences (Mills et al. 1993; Fiedler 1997; Wilkinson et al. 1998; Fiedler et al. 2000; Kumaranayake and Watts 2000b; Kumaranayake et al. 2001; Saitowitz et al. 2001; Schwartlander et al. 2001; UNECA 2001; World Bank and ACTafrica 2001) , one adjusted costs for fixed and semi-fixed costs , one included an analysis of unutilized human resource capacity and bulk procurement of drugs (Khan et al. 2002) , and seven included costs for improving the operational capacity of programmes (Wilkinson et al. 1998 ; Kumaranayake and The analysis and discussion sections of the papers were used to determine factors that could indicate a change in average cost is needed when health interventions are scaled up. These factors were classified into broad categories. Human resource limitations and geography and infrastructure affect primarily prices for goods and services, increasing prices at higher coverage levels, while the extent of fixed costs and variable costs associated with the process of scaling up are driven primarily by the increased quantities of resources needed. There is overlap in this classification, and it is intended only as a base for discussion.
Results and discussion
The results for the two objectives of this paper are discussed in turn. To facilitate comparisons, all costs are adjusted to a base year (1998) using GDP deflators (World Bank 2000) , and converted to international dollars (I$) using purchasing power parity exchange rates 2 (World Health Organization 2002).
Objective 1: Identify what factors modify cost curves
Many of the studies found for this review indicate or imply that cost structures and/or technologies change in different settings or at different coverage levels, but do not give a full quantitative analysis of these findings, or do not report their findings/results for different coverage levels. However, these studies provide insight into the variables that need to be considered when accounting for the cost of scaling up. 3 This section reviews the factors that the analyses considered when adjusting costs to account for scaling up. When relevant, examples from the analyses that assessed programmes after the process of scaling up had occurred are included to highlight the importance of the factors. Table 4 summarizes this discussion.
Geography and infrastructure
Many of the analyses surveyed assumed or showed that in general average cost in rural areas is higher than in urban areas (e.g. Kumaranayake and Watts 2000b) . The higher price of transport, supervision and training due to greater distances travelled and difficult terrain in remote areas is one reason costs are higher in rural areas, and these inputs cause diseconomies of scale (Over 1986; Kass 1987; Fiedler 1997; DeRoeck and Levin 1998; Fiedler et al. 2000; Kumaranayake and Watts 2000b; Hanson et al. 2001; Saitowitz et al. 2001 ; see also Uys and Hensher 2002) . Fiedler (2001) found the training costs in remote and mountainous districts covered between 1996 and 2000 had a higher cost per trainee than districts covered before 1996, and that the average cost per kilogram for transporting vitamin A capsules to Nepal's mountainous areas is I$2.92, while to hill districts it is I$1.06 and to the lowlands it is I$0.52 (Fiedler 2001) . The nearly six-fold difference in transport price is the product of both the distance of districts from the central shipping point (in Kathmandu) and the difficulty of shipping.
The process of scaling up may be further complicated in the short run by a lack of physical infrastructure in the usually underdeveloped rural areas (Cumper 1987; Phillips 1993; Kumaranayake and Watts 2000a; Hanson et al. 2001) . Lack of roads, supply chain and other basic infrastructure elements may hinder the ability of a country to scale up, make communication and training more difficult, or otherwise substantially increase prices in new areas of coverage. Additionally, remote areas are more likely to have less highly trained personnel, requiring more supervision, support and motivation (Mills et al. 1993; Fiedler 1997 Fiedler , 2001 Kumaranayake and Watts 2000b; Hanson et al. 2001; Saitowitz et al. 2001 ; see also Perry and Gesler 2000) .
Human resources
A costing study needs to assess the extent to which unused capacity in human resources would permit an intervention to be scaled up. Without trained health professionals and management personnel to implement a programme, policy makers cannot realistically anticipate that a programme will be effectively scaled up (Over 1986; Cumper 1987; Mills et al. 1993; Wilkinson et al. 1998; Kumaranayake and Watts 2000b; Hanson et al. 2001; Wyss et al. 2001 ). As such, lack of human resources constitutes one of the most binding constraints to scaling up in the short run (Hanson et al. 2001) . While the cost of recruiting, training and retaining skilled personnel must be accounted for when considering the cost of scaling up (Wilkinson et al. 1998) , only three of the studies reviewed contain a detailed analysis of the human resource constraints that would be faced as a programme is scaled up (Wilkinson et al. 1998 (Wilkinson et al. , 2000 Khan et al. 2000) . Additionally, Fielder (1997 found the Nepal vitamin A programme used an existing community health worker network (Fiedler 2001) . Thus, there was no human resource constraint, but if this network had not pre-dated the programme, setting it up would have incurred additional costs. 
Variety
Developing countries † Unit costs times projected people in need used as base line † 15% added for management costs † 15% added for monitoring costs † 10-25% added for quality improvement † 100% increase in salaries for all staff Levin et al. (2001) Immunization Ghana † At base level, multiplied current variable cost by projected need † Cost included upgrading the delivery system, which incorporated fixed cost for training and outreach and variable costs Saitowitz et al. (2001) Vitamin A South Africa † Costs for national programme based on use of existing health infrastructure † Fixed cost at national level † Different places calculated to need different amount of staff time depending on demand (cost per client variable) † Different training/travel costs for each province.
Small variation in transport cost for Vitamin A capsules Khan et al. (2002) Childhood diseases at primary health care facilities Bangladesh † Analyzes recurrent costs associated with programme (fixed costs assumed ongoing, i.e. economies of scope) † Accounts for economies of scale through bulk drug procurement † Analyzes human resource needs separate from costs Expansion into rural areas may entail offering incentives to health personnel to locate in these areas, although there is mixed evidence on the effectiveness of these types of programmes (Over 1986; Soucat et al. 1997) . Some studies, primarily from developed countries, show that where a person is from, where they train and career possibilities are the most influential factors in location decisions for health personnel, especially doctors. Thus, staffing shortages can be addressed over the long run by building medical schools in under-served areas, redesigning residency programmes to include a rotation or pre-qualification in rural areas etc., and even then such interventions are often limited in their effects (Anderson and Rosenberg 1990; Edginton and Holst 1991; Kristiansen and Forde 1992; Connor et al. 1995; Madianos et al. 1999) . Such approaches may not be possible in many countries, and other models or studies argue that fiscal incentives can influence doctors' decisions and may be cheaper than other alternatives (Hurley 1990; Chomitz et al. 1998 ; Hammer and Jack 2002).
Often, when human resources are a constraint, completely different implementation models or technologies need to be employed (Farmer et al. 2001; Nsutebu et al. 2001 ). In the short run, task shifts (e.g. shifts of administrative/recording/ reporting work to other staff) can be implemented to free up a health professional's time, and outreach services can be implemented (Mercer et al. 2002) . Soucat et al. (1997) argue that rural areas of northern Benin also had lower overall operating costs due to 'severe' understaffing, indicating that either some constraints to scaling up needed to be addressed with incentives to staff, or that there was a shortage of trained personnel to implement the initiative in that country.
Questions related to human resources also go beyond a lack of supply and should consider poor distribution of human resources within a country (geographic imbalance, service imbalance, public/private imbalance, etc.) and poor Khan et al.(2002) productivity, each of which would require a different solution (Mercer et al. 2002) .
The extent of fixed costs
The traditional argument for decreasing marginal costs involves spreading fixed costs over more people as output increases. For example, as more patients utilize a heath service unit, the cost per patient becomes lower (Mills et al. 1993; Phillips 1993; Soucat et al.1997; DeRoeck and Levin 1998; Gonzales et al. 1998; Fiedler et al. 2000; Kumaranayake and Watts 2000b; Saitowitz et al. 2001; Valdmanis et al. 2003) . There is some evidence that larger hospitals (up to a point) have a lower average cost per patient due to spreading the fixed costs of services over more people, although the evidence comes primarily from developed countries (c.f., Long et al. 1985; Dranove 1998; Karlsson and Johannesson 1998) .
For reasons of equity or equal access, health centres in rural areas are often located such that they cannot possibly serve the equivalent number of people as urban or semi-urban health centres (Stock 1983; De Winter 1992; Ali et al. 2001; Khan et al. 2001 ). The fixed costs of rural health centres are, thus, spread over fewer people (Soucat et al. 1997) . Studies for a number of different interventions find that rural health centres have a higher cost per patient (Berman 1989; Berman et al. 1989; Berman and Sakai 1993; Doherty et al. 1996; Fabricant et al. 1999 ), while only one study comparing costs within an urban district shows ambiguous findings (Forsythe et al. 2002) .
In Berman et al.'s Indonesia study, the average cost ranges from I$0.09 to I$0.42, with an increase in service output strongly associated with a drop in average costs ). This indicates diseconomies of scale; the costs of treating a patient in rural areas will be higher than in urban areas and must be considered when scaling up interventions. Khan et al. (2002) , on the other hand, argue that current use of public health facilities in Bangladesh is so low that increasing service provision will result in negative marginal costs. Over (1986) argues that health interventions are most likely to be started in urban areas, because these areas are the easiest in which to supervise, manage, supply and recruit personnel, and to build in. Rural areas, then, will have higher average costs for the above reasons. Further, it is less likely that the rural population will be as familiar with the health care infrastructure, and may need more educational outreach for them to utilize the resources. Finally, Over (1986) argues that there will be some economies of scale as the central administration is spread over more health care centres, but that these economies of scale are likely to be exhausted more rapidly in rural areas since these areas require more staff time for supervision, training etc. However, in rural areas, it may be more feasible or cheaper to employ alternative technologies, such as campaigns, outreach or mobile facilities, to reach a remote population, although these technologies will still be more expensive per patient than the average cost in urban areas (Brenzel and Claquin 1994) . Some programmes may have very high development costs, or incur costs only at a central level, indicating long-run economies of scale. Food fortification programmes, for example, may incur costs at central manufacturing points no matter the consumption level of the product (Fiedler et al. 2000) . Mills et al. (1993) note that the total cost of mass media programmes tends to be very similar in countries of different populations due to the high initial cost of production, and thus should have economies of scale with more coverage or in larger countries. Brenzel and Claquin (1994) find that increasing the number of children immunized is associated with a decrease in cost per child. These lower average costs come primarily from the high fixed cost of operating an immunization programme compared with the low variable costs for vaccines. There are some indications in the paper that diseconomies of scale also exist. Rural Tanzania, for example, reported high levels of vaccine wastage, possibly due to lack of demand, indicating that average cost in rural areas is higher than in urban areas.
In some cases, increasing coverage can exceed the capacity threshold for some capital goods. For example, a delivery car may be able to deliver additional antigens for an immunization programme, but increasing coverage into a new district of the country may require an additional car, no matter what the coverage in that district is. This causes the short-run average cost curve to jump when the district border is crossed, but then decline until the next border is reached (step function) (Karlsson and Johannesson 1998) . Hart et al. (1991) argue that these semi-fixed costs can have a significant impact on the total cost of a plasma collection programme at the local level.
Obtaining estimates on the extent to which fixed or semi-fixed costs impact total costs is difficult because only a few studies break costs into fixed and variable costs, and because the percentage of total costs comprised by fixed cost changes with coverage. An analysis of the projections presented for a Vitamin A programme in Nepal show that, at the beginning of the programme, fixed costs, consisting of programme planning and administration, comprised almost 47% of total costs, but after expansion, were projected to constitute only 31% of costs (Fiedler 1997) . The follow-up study shows that significant streamlining in the administration of the programme resulted in fixed costs dropping to only about 5% of total costs (if they had continued at previous levels, they would have constituted 19% of costs), substantially less than at lower coverage levels (Fiedler 2001) .
Managing the process of scaling up
The management of a programme must be accounted for in the costing process. These concerns tend to be more important in the short run because they represent problems in utilizing an existing infrastructure (physical or human capital). During the process of scaling up, for example, there is an increased need for communication among the various levels of personnel implementing the programme (Cumper 1987; Hanson et al. 2001 ). Managers of a pilot programme train new staff and share their knowledge in follow-up visits to new sites, which incurs costs beyond what is included in the usual operating budget of the pilot programme (Lovell and Abed 1993; Uvin 1995; Sternin et al. 1998) . This is in addition to the time spent to win political support for scaling up (Simmons et al. 2002) .
The cost and effectiveness of scaling up depend on the patient demand for the services offered (Over 1986; Phillips 1993; Brenzel and Claquin 1994; DeRoeck and Levin 1998; Fiedler 2001; Hanson et al. 2001; Levin et al. 2001 ; see also Sauerborn et al. 1989; Perry et al. 1998; Borgdorff et al. 2002) . Programmes such as educational outreach or mass media campaigns often have to accompany scaling-up in order to create demand for a service. This is especially true for a subpopulation, such as women, ethnic minorities, people speaking a different language, or immigrants (Levin et al. 2001) . Lack of quality in health provision often will dampen demand for services (Annis 1981; Fabricant et al. 1999) , which may in turn affect cost; however, only two reviewed studies included a quantitative analysis of this type, arguing that increased demand would lower average costs (Soucat et al.1997; Khan et al. 2000) .
The process of scaling up may be further complicated by a lack of administrative infrastructure. If a country lacks a functioning health information system, for example, one may need to be established for some programmes to be scaled up (Osiobe 1989) . This is coupled with the need for quality assurance in newly covered areas (Soucat et al. 1997; Gonzales et al. 1998; Hanson et al. 2001; Levin et al. 2001; Saitowitz et al. 2001 ). Supervision and monitoring may have increased costs for reasons discussed above, but may also suffer from diseconomies of scope if activities grow too large and complex to manage (Berman et al. 1987; Valdmanis et al. 2003) . A specific programme to enhance the managerial and supervisory abilities of personnel can accompany an effort at scaling up (c.f., Kafle et al. 1992; Loevinsohn et al. 1995; Conn et al. 1996) . With time, however, programmes can 'learn as they go', or operate more efficiently due to shifting management techniques or the use of new technologies (Over 1986; Fiedler 2001; Seshadri 2001 ). Fielder (1997 shows the cost per child reached fell from I$3.29 -4.00 in 1996 to I$3.14 in 2000. This drop in average costs is accounted for in part by structural reorganizations at the central level, which reduced the cost of transportation and training per diems, and the central staff of administrators and trainers taking on the additional workload inherent in scalingup without any additional hiring.
In general, scaling up several interventions simultaneously may produce diseconomies of scope as the current infrastructure is overwhelmed. Kumaranayake and Watts (2000a) demonstrate that scaling up both preventive and curative interventions against HIV/AIDS produces larger diseconomies of scale than scaling up each set separately, especially in countries with a low level of pre-existing health infrastructure.
However, scaling-up may realize economies of scope by piggybacking on current under-utilized capacity (Phillips 1993; DeRoeck and Levin 1998; Saitowitz et al. 2001) . The classic example is that offering an additional vaccine antigen in an already established immunization programme has significantly lower costs than offering the vaccine in a separate programme. Edmunds et al. (2000) , for example, find that 79% of the incremental cost of introducing the HBV vaccine into the EPI programme in rural Ethiopia comes directly from the cost of the vaccine, while other antigens account for only 28% of the total cost of the current EPI programme. The discrepancy between these two percentages comes from greater utilization of the current capital stock (buildings, refrigerators etc.) and the small amount of additional training necessary to introduce a new vaccine. Further, programmes operating at a large scale may be able to benefit from buying items, such as drugs or condoms, in bulk, thus reducing the cost per unit (Mills et al. 1993; Kumaranayake and Watts 2000b; Fiedler 2001; Khan et al. 2002) .
Objective 2: Describe cost curves for different kinds of interventions and levels of coverage The data presented in these studies do not lend themselves to a quantitative synthesis for several reasons. The reviewed programmes use different methodologies to assess scaling up and this heterogeneity makes synthesis of the data problematic. Another source of heterogeneity is that the programmes themselves are different in nature and took place in different contexts. Finally, since there are only a few studies with data relevant for any single type of programme, a synthesis analysis is not possible and the second objective of this paper cannot be answered. The examples below thus only compare costs (or projected costs) at different coverage levels, and the findings are only suggestive. While these examples highlight the difficulty in comparing programmes across settings, they also support the notion that average costs do change at different coverage levels and in different settings. Figure 1 presents the findings in Brenzel and Claquin (1994) , Soucat et al. (1997) , DeRoeck and Levin (1998) and Levin et al. (2001) , that look at the cost of immunization programmes. Only programmes employing fixed facilities are used in this analysis in order to hold technology constant. The percentage of children receiving vaccines is derived from the study (Soucat et al.1997) for health centres or using Figure 1 . Findings from four studies on the cost of immunization programmes the percentage of children receiving measles immunizations in the country as a whole as a proxy for coverage. Due to the differences in the costing techniques used in the different studies, the results in the Figure are only suggestive, 4 but they point to a declining average cost from about 45% to 65% coverage, with a jump up in average costs by 80% coverage. The low cost observation near 80% coverage comes from Tanzania. Brenzel and Claquin (1994) offer no concrete explanation for this discrepancy. The observations of higher costs near 80% coverage also probably include substantial outreach costs (for Turkey, the Philippines and Ghana) which are not a factor in other cases, indicating that additional technologies may be necessary to increase coverage past a threshold somewhere around 65 -75% (implying a step increase in average costs), while the low average costs in Tanzania may represent a high level of demand for services in that country.
Three other studies, all with at least one author in common, detailed the cost of Vitamin A capsule distribution, with two representing cost projections; these are summarized in Table 5 (Fiedler 1997; Fiedler et al. 2000; Saitowitz et al. 2001) . The comparison suggests some problems in comparing costs from different settings; while most studies use purchasing power parity exchange rates to compare costs, in this case official exchange rates show results that, on the surface, appear more valid. A more in-depth study than is possible here is needed to assess which analysis is more correct. All three use a methodology of costing at a provincial or district level to account for differences in travel time and training costs. The authors of one of these studies initially anticipated using a single average cost figure across the Philippines, but found the data were not compatible with that assumption (Fiedler et al. 2000) . A vitamin A capsule distribution in South Africa intended to reach 3.2 million children was estimated to cost I$3.51 per child reached (Saitowitz et al. 2001) . The average cost per beneficiary appears to be lower than the Nepal figures due to lower training costs, both because pre-existing staff in South Africa have higher skill levels than those in Nepal, and because transportation is less costly. Further, the cost for the Philippines and South Africa includes the salaries of local health workers, while it is not included in the Nepal studies. This factor helps explain the difference in costs between the Philippines and Nepal, while further emphasizing the low costs in South Africa in relation to the other countries. The high cost per child in the rural areas of the Philippines suggests that high fixed costs and difficulties in accessing and managing remote areas are quite pronounced, while findings for remote areas in South Africa show a much lower increase in average costs.
A few studies used econometric models to predict costs (Kass 1987; Kumaranayake and Watts 2000a; Kumaranayake et al. 2001) . The independent variables used and found to be significant in these models include: quantity of services provided (current coverage), total costs and/or unit costs, wage indexes, indexes for the level of health care infrastructure, urban/rural dummies, variables for client characteristics (including if they are on public insurance, or population characteristics such as number of orphans), and type of service provided (e.g. care or prevention). The dependent variable is either total costs or unit costs.
Summary and recommendations
This review of the literature argues that the costs of scaling up an intervention are specific to both the type of intervention and its particular setting. Thus, the second objective of this study, to identify typical cost curves for health interventions, was not achieved. This failure stems from a lack of data and the difficulty in transferring costs across settings.
There are three reasons for the difficulty in transferring costs across countries. First, purchasing power parity exchange rates, which most studies use to put costs into a common metric for comparison, may not capture differences in health care costs (Wordsworth and Ludbrook, forthcoming) . For example, one recent guideline recommends adjusting costs using a more health-system focused model (Mulligan et al. 2003) , or, for labour intensive programmes, others suggest adjusting costs based on wages (Kass 1987) . Secondly, most studies do not report costs in a way that makes the findings easily transferable from the study setting to other settings (Spath et al. 1999; Adam et al. 2003; Scotland et al. 2003) . This lack of transferability may be due to lack of data in publications (Spath et al. 1999; Adam et al. 2003) . Thirdly, lack of transferability may also be due to different staffing and infrastructure levels in different countries, which influence how and if programmes can be implemented in a particular setting (Wilkinson et al. 1998; Scotland et al. 2003) ; thus, reports of resource use would also increase the usefulness of This study also shows that there are general trends in the literature which can serve as guidelines applicable to a wide range of interventions and settings. First, average costs should be calculated for different areas, most notably urban and rural areas. Local training costs and per diem rates can be used to increase the sensitivity of the cost projections within a country. If possible, differences in transportation costs for supplies between different parts of the country should be included. Finally, use of different technologies (e.g. fixed facilities and mobile facilities) should be considered for the appropriate areas.
Secondly, the specific nature of the programme being costed needs to be fully understood in order to determine what is a fixed, semi-fixed or variable cost, and when possible, dis/economies of scale should be identified. One possible method is to use computer applications such as Geographic Information Systems to define catchment areas for health centres for determination of the population the fixed costs will be spread over (Khan et al. 2001) .
Thirdly, there must be an assessment of the availability and capacity of human resources. The cost of the human resources needed to implement scaling-up is perhaps the hardest to project. However, current incentives and salaries in various parts of the country can be used to determine future costs. In areas that are understaffed, data from other countries or projections of programmes to recruit or train personnel must be incorporated; alternatively, health-sector wide programmes for the management, recruitment and training of human resources can be incorporated. Khan et al. (2002) provide perhaps the best example of this kind of analysis, using timemotion studies to determine resource needs (although they do not account for changing time needs as a programme becomes more familiar to the staff). Even lacking such detailed information, rough assessments should be made to determine if a programme is feasible.
Finally, a total cost figure should include the costs of managing the scaling-up process itself. An analysis of the extra activities required for scaling up, including the cost of training, communication, meetings and evaluation, is required. Considerations of time can also be incorporated, with programmes that are scaled up slowly over time including a mark down in management costs for learning and innovation. Alternatively, programmes that are projected to be scaled up in a short time span must include the full cost of managing this transition. The cost of managing the scaling up of a health intervention also varies depending on the health infrastructure present in a country. Total costs should include the cost of outreach to new populations when appropriate. If the total cost estimate is reported as incremental to current costs, it should also include economies of scope by estimating the unutilized capacity of the current personnel and equipment that could be exploited when scaling up the new intervention. This type of analysis can also determine which items can be bought in bulk, and account for potential savings in this area.
The econometric studies found in this survey do include variables that capture many of the factors discussed in this paper (Kass 1987; Kumaranayake and Watts 2000a; Kumaranayake et al. 2001) . For example, they often include variables for the scale of a programme, with the number of patients usually serving as a proxy, and all include urban/rural variables. Costs are often made more comparable by using purchasing power parity exchange rates or a wage index. None included variables for length of time a programme had been implemented, speed of scaling up, or other variables to capture the changing cost structure associated with managing the process of scaling up. Nor were the distances involved captured in these models, although recent studies unrelated to health suggest this is possible (Limao and Venables 2001) . Two of the studies (Kumaranayake and Watts 2000a; Kumaranayake et al. 2001 ) include variables to account for current health system infrastructure, including human resources, and suggest that these factors impact costs. The extent to which human resources represent a capacity constraint to scaling up is not explored in these studies. However, these studies show that many of the variables discussed in this survey do have a statistically significant impact on costs. Further econometric studies may suggest the significance or impact of variables that were not considered in these three studies.
This study is limited by the surprising scarcity of real data reported in the public domain that specifically address the issue of costs when scaling up health interventions. Reliable, quantitative data for many of the variables identified in this paper are lacking; rather, the studies surveyed suggest or indicate that there are important variables to consider when evaluating the cost of scaling up. Further, there are not enough data points to construct or derive typical cost curves. Thus, we recommend further research on and reporting of the actual costs of scaling up for health interventions as countries and international programmes implement their plans to reach the MDGs. These studies should include assessments of fixed, semi-fixed and variable costs, consider economies of scope, infrastructure constraints and constraints related to human resources.
Endnotes
1 The literature search was conducted in English; thus, any studies from Latin America or Eastern Europe published in other languages were not captured, representing a potential bias in this review.
2 An international dollar has the same purchasing power as the US dollar has in the United States. Costs in local currency units are converted to international dollars using purchasing power parity (PPP) exchange rates. A PPP exchange rate is the number of units of a country's currency required to buy the same amounts of goods and services in the domestic market as the US dollar would buy in the United States. An international dollar is, therefore, a hypothetical currency that is used as a means of translating and comparing costs from one country to the other using a common reference point, the US dollar. The PPP exchange rates used in this analysis were developed by WHO and are available on the WHO-CHOICE website. Note, however, that it is debatable whether PPP provides a better adjustment to health sector costs than official exchange rates (Wordsworth and Ludbrook, forthcoming).
The use of PPP exchange rates generally results in cost figures higher than figures reported using US dollars.
3 Only for the six studies which evaluate costs after scale-up or using econometric analysis can the variables used be considered concrete evidence. In the other 15, the adjustments using these variables were imposed by the analyst and can be considered only indicative. 4 While using data only from health facility-based immunization programmes in order to hold technology constant, there was no means to ascertain if the same bundle of antigens was used. Thus, differences in costs may reflect to some degree differences due to different antigen packages. Also, the different levels of efficiency in programme operation between the countries will affect the average costs. Finally, the Soucat et al. (1997) study gives coverage for a health centre's catchment areas, which may not be comparable with national coverage figures; however, the similarity of these findings with the results from Levin et al. (2001) for Senegal indicate they may be comparable.
